OLD National Bancorp IN Decreases Stock Position in Encompass Health Co. (NYSE:EHC)

OLD National Bancorp IN lessened its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 79.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,000 shares of the company's stock after selling 31,020 shares during the quarter. OLD National Bancorp IN's holdings in Encompass Health were worth $534,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. McGlone Suttner Wealth Management Inc. acquired a new stake in Encompass Health during the 4th quarter valued at $30,000. C M Bidwell & Associates Ltd. acquired a new stake in shares of Encompass Health in the 3rd quarter valued at $35,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Encompass Health in the 3rd quarter valued at $109,000. Acadian Asset Management LLC acquired a new stake in shares of Encompass Health in the 3rd quarter valued at $111,000. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Encompass Health by 14.7% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company's stock valued at $182,000 after buying an additional 347 shares during the period. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Down 0.1 %

Shares of Encompass Health stock traded down $0.06 during trading on Thursday, reaching $82.74. The stock had a trading volume of 1,488,277 shares, compared to its average volume of 671,911. The company has a market capitalization of $8.29 billion, a price-to-earnings ratio of 23.84, a P/E/G ratio of 1.53 and a beta of 0.94. The stock has a fifty day moving average price of $78.07 and a two-hundred day moving average price of $70.76. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $85.84. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.19. The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The company's quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.88 earnings per share. Sell-side analysts predict that Encompass Health Co. will post 3.96 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a $0.15 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.73%. Encompass Health's dividend payout ratio (DPR) is 17.29%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on EHC. Royal Bank of Canada reissued an "outperform" rating and issued a $83.00 target price on shares of Encompass Health in a research note on Friday, February 9th. Truist Financial raised their price target on Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a research report on Friday, February 9th. Barclays raised their price target on Encompass Health from $101.00 to $108.00 and gave the stock an "overweight" rating in a research report on Thursday. Mizuho raised their price target on Encompass Health from $93.00 to $95.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, Stephens restated an "overweight" rating and issued a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Eight investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $85.44.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.